Associate Professor Department of Anesthesiology and Pain Medicine,
Seoul, 120-752, South Korea
NCT Number: NCT02813044
A number of studies have compared the effects of total intravenous anesthesia(TIVA) versus inhalational anesthesia on perioperative period during transsphenoidal surgery. However, they have limitations especially for the phase of recovery after anesthesia: a fragmentary assessment. Quality of Recovery 40 (QoR-40) questionnaire was multi-dimensionally designed to assess the degree of recovery, specially after anesthesia and surgery. In this study, the investigators aim to compare the quality of recovery after inhalational anesthesia and after TIVA through QoR-40 questionnaire in patients undergoing transsphenoidal surgery for pituitary tumor under general anesthesia.
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Not applicable
Seoul, 120-752, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the TIVA group,anesthesia is induced and maintained by effect-site target controlled infusion of propofol and remifentanil.
In the inhalation anesthesia group, anesthesia is induced by pentothal sodium 4-6mg/kg and remifentanil 1 μg/kg, and then maintained with end-tidal sevoflurane concentration of 0.8 to 1 MAC and continuous infusion of remifentanil at 0.1-0.3μg/kg/min.
Time frame: 1 day
We compare the QoR-40 scores of two groups 1 day after the operation.
Yonsei University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04042753
Brain Diseases, Brain Neoplasms
Los Angeles, California, United States
View Trial DetailsNCT03677713
Brain Diseases, Brain Neoplasms
Ottawa, Ontario, Canada
View Trial DetailsNCT03636568
Brain Diseases, Brain Neoplasms
St Louis, Missouri, United States
View Trial DetailsNCT01556230
Brain Diseases, Brain Neoplasms
New York, United States
View Trial Details